{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:46:55Z","timestamp":1790876815747,"version":"4.1.0"},"reference-count":51,"publisher":"American Academy of Pediatrics (AAP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:p>Placenta accreta spectrum (PAS) refers to the range of pathologic adherence of the placenta to the uterine myometrium, including the placenta accreta, increta, and percreta. The incidence of PAS is rising primarily because of an increase in related risk factors, such as the rate of cesarean deliveries and pregnancies resulting from assisted reproductive technology. The maternal risks associated with PAS are significant, including hemorrhage, hysterectomy, and death. Fetal and neonatal risks are primarily the result of premature delivery. Antenatal diagnosis via ultrasonography and magnetic resonance imaging remains imperfect. Management of PAS varies, however, and there is a clear improvement in maternal outcomes with an antenatal diagnosis compared with unexpected diagnosis at the time of delivery. Studies that evaluate the balance between maternal and fetal\/neonatal risks of expectant management versus preterm delivery have found that planned delivery between 34 and 35 weeks\u2019 gestation optimizes outcomes. Multidisciplinary PAS care teams have become the norm and recommended approach to management, given the complexity of caring for this obstetrical condition. Although significant advances have been made over the years, large knowledge gaps remain in understanding the pathophysiology, diagnosis, and clinical management.<\/jats:p>","DOI":"10.1542\/neo.22-11-e722","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T09:35:13Z","timestamp":1635759313000},"page":"e722-e733","source":"Crossref","is-referenced-by-count":17,"title":["Placenta Accreta Spectrum"],"prefix":"10.1542","volume":"22","author":[{"given":"Bridget M.","family":"Donovan","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA"},{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Shainker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA"},{"name":"Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"issue":"6","key":"2021121010325167600_B1","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","article-title":"Obstetric care consensus no. 7: placenta accreta spectrum","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"16","key":"2021121010325167600_B2","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"2021121010325167600_B3","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2021121010325167600_B4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3109\/14767058.2015.1034103","article-title":"Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011","volume":"29","author":"Mogos","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"2021121010325167600_B5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.placenta.2008.04.008","article-title":"Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast","volume":"29","author":"Tantbirojn","year":"2008","journal-title":"Placenta"},{"issue":"3","key":"2021121010325167600_B6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"3 pt 2","key":"2021121010325167600_B7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications","volume":"193","author":"Usta","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2 pt 1","key":"2021121010325167600_B8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/AOG.0b013e3181ad9442","article-title":"The frequency and complication rates of hysterectomy accompanying cesarean delivery","volume":"114","author":"Shellhaas","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2021121010325167600_B9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e3181c4f12a","article-title":"Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta","volume":"115","author":"Warshak","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2021121010325167600_B10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2010.09.013","article-title":"Placenta accreta","volume":"203","author":"Belfort","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2021121010325167600_B11","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2019.05.035","article-title":"Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team","volume":"221","author":"Erfani","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021121010325167600_B12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1471-0528.12557","article-title":"The antenatal diagnosis of placenta accreta","volume":"121","author":"Comstock","year":"2014","journal-title":"BJOG"},{"issue":"5","key":"2021121010325167600_B13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/uog.13194","article-title":"Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis","volume":"42","author":"D\u2019Antonio","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"2021121010325167600_B14","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.09.001","article-title":"Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum","volume":"224","author":"Shainker","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2021121010325167600_B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2021121010325167600_B16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/AOG.0b013e3181f3588d","article-title":"Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta","volume":"116","author":"Robinson","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2021121010325167600_B17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","article-title":"Center of excellence for placenta accreta","volume":"212","author":"Silver","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021121010325167600_B18","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2014.08.019","article-title":"Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach","volume":"212","author":"Shamshirsaz","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2021121010325167600_B19","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121010325167600_B20","doi-asserted-by":"crossref","first-page":"384.e1","DOI":"10.1016\/j.ajog.2015.05.002","article-title":"Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor?","volume":"213","author":"Creanga","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2021121010325167600_B21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal morbidity associated with multiple repeat cesarean deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121010325167600_B22","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2012.12.037","article-title":"Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births","volume":"208","author":"Eshkoli","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2021121010325167600_B23","first-page":"799","article-title":"Risk factors for placenta accreta: a large prospective cohort","volume":"31","author":"Bowman","year":"2014","journal-title":"Am J Perinatol"},{"issue":"2","key":"2021121010325167600_B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0000000000002434","article-title":"Antecedents of abnormally invasive placenta in primiparous women: Risk associated with gynecologic procedures","volume":"131","author":"Baldwin","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2021121010325167600_B25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(97)70463-0","article-title":"Clinical risk factors for placenta previa-placenta accreta","volume":"177","author":"Miller","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"223","key":"2021121010325167600_B26","first-page":"e1","article-title":"In vitro fertilization as an independent risk factor for placenta accreta spectrum","volume":"568","author":"Salmanian","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2021121010325167600_B27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.fertnstert.2015.01.021","article-title":"Cryopreserved embryo transfer is an independent risk factor for placenta accreta","volume":"103","author":"Kaser","year":"2015","journal-title":"Fertil Steril"},{"key":"2021121010325167600_B28","article-title":"Placenta accreta spectrum: in vitro fertilization and non-in vitro fertilization and placenta accreta spectrum in a Massachusetts cohort [published online ahead of print July 5, 2020]","author":"Modest","journal-title":"Am J Perinatol"},{"issue":"5","key":"2021121010325167600_B29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0000000000003793","article-title":"Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion","volume":"135","author":"Einerson","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"12","key":"2021121010325167600_B30","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41379-020-0569-1","article-title":"Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel","volume":"33","author":"Hecht","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"2021121010325167600_B31","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","article-title":"Placenta accreta spectrum","volume":"219","author":"Cahill","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2021121010325167600_B32","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.01.030","article-title":"Society for Maternal-Fetal Medicine (SMFM) consult series #49: cesarean scar pregnancy","volume":"222","author":"Miller","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2021121010325167600_B33","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/j.jacr.2020.01.031","article-title":"ACR Appropriateness Criteria\u00ae Placenta Accreta Spectrum Disorder","volume":"17","author":"Poder","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"1114","key":"2021121010325167600_B34","doi-asserted-by":"crossref","first-page":"20200267","DOI":"10.1259\/bjr.20200267","article-title":"MRI of placenta accreta: diagnostic accuracy and impact of interventional radiology on foetal-maternal delivery outcomes in high-risk women","volume":"93","author":"Fiocchi","year":"2020","journal-title":"Br J Radiol"},{"issue":"6","key":"2021121010325167600_B35","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.ajog.2018.03.013","article-title":"Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders","volume":"218","author":"Einerson","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2021121010325167600_B36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","article-title":"Optimal management strategies for placenta accreta","volume":"116","author":"Eller","year":"2009","journal-title":"BJOG"},{"issue":"6","key":"2021121010325167600_B37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2015.04.034","article-title":"Conservative management of morbidly adherent placenta: expert review","volume":"213","author":"Fox","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121010325167600_B38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijgo.12410","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management","volume":"140","author":"Sentilhes","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"2021121010325167600_B39","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.ajog.2019.05.046","article-title":"Obstetric care consensus #9: levels of maternal care: (replaces obstetric care consensus number 2, February 2015)","volume":"221","author":"Kilpatrick","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121010325167600_B40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12409","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management","volume":"140","author":"Allen","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2021121010325167600_B41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/GRF.0000000000000393","article-title":"The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta","volume":"61","author":"Shamshirsaz","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"16","key":"2021121010325167600_B42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3109\/14767058.2013.793662","article-title":"Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta","volume":"26","author":"Wright","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2021121010325167600_B43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/14767058.2011.598585","article-title":"PAMUS: placenta accreta management across the United States","volume":"25","author":"Esakoff","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"14","key":"2021121010325167600_B44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2021121010325167600_B45","doi-asserted-by":"crossref","first-page":"433.e1","DOI":"10.1016\/j.ajog.2020.03.019","article-title":"Placenta accreta spectrum: biomarker discovery using plasma proteomics","volume":"223","author":"Shainker","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2021121010325167600_B46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021121010325167600_B47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00404-017-4432-7","article-title":"Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation","volume":"296","author":"Shainker","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2021121010325167600_B48","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2013.08.032","article-title":"Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta","volume":"210","author":"McMahon","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021121010325167600_B49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00404-020-05453-1","article-title":"Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders","volume":"301","author":"Hecht","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"15","key":"2021121010325167600_B50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.21037\/atm-20-1150","article-title":"Development and validation of a four-microRNA signature for placenta accreta spectrum: an integrated competing endogenous RNA network analysis","volume":"8","author":"Yang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2021121010325167600_B51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.placenta.2020.06.006","article-title":"A mouse model of placenta accreta spectrum","volume":"99","author":"Burke","year":"2020","journal-title":"Placenta"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/11\/e722\/1192667\/neoreviews_072021o00116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/11\/e722\/1192667\/neoreviews_072021o00116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T23:11:33Z","timestamp":1639177893000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/22\/11\/e722\/181268\/Placenta-Accreta-Spectrum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.22-11-e722","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}